|
Ullrich N, Loffek S, Horn S, Ennen M, Sanchez-Del-Campo L, Zhao F, Breitenbuecher F, Davidson I, Singer BB, Schadendorf D, Goding CR, Helfrich I. MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma. Pigment Cell Melanoma Res. 2015 Nov;28(6):736-40. doi: 10.1111/pcmr.12414. PubMed PMID: 26301891.
AÑO: 2015; IF: 4.3
|
26301891
|
Montenegro MF, Sánchez-del-Campo L, Fernández-Pérez MP, Sáez-Ayala M, Cabezas-Herrera J, Rodríguez-López JN. Targeting the epigenetic machinery of cancer cells. Oncogene. 2015 Jan 8;34(2):135-43. doi: 10.1038/onc.2013.605. Review. PubMed PMID: 24469033.
AÑO: 2015; IF: 7.932
|
|
Sacilotto N, Monteiro R, Fritzsche M, Becker PW, Sanchez-Del-Campo L, Liu K, Pinheiro P, Ratnayaka I, Davies B, Goding CR, Patient R, Bou-Gharios G, De Val S. Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development. Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11893-8. doi: 10.1073/pnas.1300805110. Epub 2013 Jul 1. PubMed PMID: 23818617; PubMed Central PMCID: PMC3718163.
AÑO: 2013; IF: 11.1
|
|
Fernández-Pérez MP, Montenegro MF, Sáez-Ayala M, Sánchez-del-Campo L, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma. Neoplasia. 2013 Jul;15(7):826-39. PubMed PMID: 23814494; PubMed Central PMCID: PMC3689245.
AÑO: 2013; IF: 5.398
|
|
Sáez-Ayala M, Montenegro MF, Sánchez-Del-Campo L, Fernández-Pérez MP, Chazarra S, Freter R, Middleton M, Piñero-Madrona A, Cabezas-Herrera J, Goding CR, Rodríguez-López JN. Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell. 2013 Jul 8;24(1):105-19. doi: 10.1016/j.ccr.2013.05.009. PubMed PMID: 23792190.
AÑO: 2013; IF: 26.602
|